| 1 |
33461346 | Erythropoietin promoter polymorphism is associated with treatment efficacy and severe hematologic toxicity for platinum-based chemotherapy. | 2021 Apr |
2 |
| 2 |
30483799 | Erythropoietin promotes expression of survivin via STAT3 activation and reduces sensitivity to cisplatin in cervical cancer cells. | 2019 Feb |
5 |
| 3 |
31135681 | EPO Attenuates Cisplatin-Induced Ototoxicity in HEI-OC1 Auditory Cell Via the Nrf2-ARE Signaling Pathway. | 2019 Aug |
5 |
| 4 |
28629521 | Erythropoietin Promotes Glioblastoma via miR-451 Suppression. | 2017 |
1 |
| 5 |
29080630 | Effect of quercetin on cell protection via erythropoietin and cell injury of HepG2 cells. | 2017 Dec 15 |
2 |
| 6 |
25758589 | Evaluation of multi-neuroprotective effects of erythropoietin using cisplatin induced peripheral neurotoxicity model. | 2015 Apr |
3 |
| 7 |
25851297 | Re: Sex differences in protective effect of recombinant human erythropoietin against cisplatin-induced nephrotoxicity in rats. | 2015 Mar |
1 |
| 8 |
24501100 | The protective effect of recombinant human erythropoietin against cisplatin-induced renal and hepatic dysfunctions in Wistar rats. | 2014 Oct |
1 |
| 9 |
21924599 | Protective effect of recombinant human erythropoeitin against cisplatin cytotoxicity and genotoxicity in cultured Vero cells. | 2013 Jan |
1 |
| 10 |
23111886 | The protective effect of recombinant human erythropoietin against cisplatin-induced renal and hepatic dysfunctions in Wistar rats. | 2013 Apr |
1 |
| 11 |
23970409 | Antioxidant and antigenotoxic role of recombinant human erythropoeitin against alkylating agents: cisplatin and mitomycin C in cultured Vero cells. | 2013 Aug 1 |
1 |
| 12 |
24072151 | Sex differences in protective effect of recombinant human erythropoietin against cisplatin-induced nephrotoxicity in rats. | 2013 Sep |
2 |
| 13 |
21834696 | Recombinant human erythropoietin prevents cisplatin-induced genotoxicity in rat liver and heart tissues via an antioxidant process. | 2012 Apr |
1 |
| 14 |
21860424 | Erythropoietin receptor contributes to melanoma cell survival in vivo. | 2012 Mar 29 |
1 |
| 15 |
23077460 | Contrasting effect of recombinant human erythropoietin on breast cancer cell response to cisplatin induced cytotoxicity. | 2012 Sep |
1 |
| 16 |
21497595 | Erythropoietin regulates apoptosis, inflammation and tissue remodelling via caspase-3 and IL-1β in isolated hemoperfused kidneys. | 2011 Jun 25 |
1 |
| 17 |
22013135 | Protective effect of recombinant human erythropoietin against cisplatin-induced oxidative stress and nephrotoxicity in rat kidney. | 2011 Oct |
2 |
| 18 |
19536148 | Role of erythropoietin receptor expression in malignant melanoma. | 2010 Jan |
1 |
| 19 |
20657614 | Recombinant human erythropoietin counteracts cisplatin-induced visceral hyperalgesia. | 2010 Aug |
2 |
| 20 |
19194548 | Post-treatment effects of erythropoietin and nordihydroguaiaretic acid on recovery from cisplatin-induced acute renal failure in the rat. | 2009 Jan |
1 |
| 21 |
19259045 | Erythropoietin reduces cumulative nephrotoxicity from cisplatin and enhances renal tubular cell proliferation. | 2008 Dec |
3 |
| 22 |
17410721 | Survival and invasiveness of astrocytomas promoted by erythropoietin. | 2007 Feb |
1 |
| 23 |
17982682 | Erythropoietin reduces cisplatin-induced neurotoxicity without impairment of cytotoxic effects against tumor cells. | 2007 Dec |
5 |
| 24 |
18075299 | Erythropoietin reduces cisplatin-induced apoptosis in renal carcinoma cells via a PKC dependent pathway. | 2007 Dec |
1 |
| 25 |
16638873 | Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity. | 2006 Apr 15 |
1 |
| 26 |
16837817 | Erythropoietin in experimental acute renal failure. | 2006 |
1 |
| 27 |
17310843 | Recombinant human erythropoietin in comparison to amifostine against cisplatin-induced peripheral sensorial neurotoxicity in rats. | 2006 Dec |
2 |
| 28 |
15739025 | Comparison of the serum erythropoietin levels in chemotherapy-naive and cisplatin-treated cancer patients. | 2005 |
4 |
| 29 |
15299192 | Erythropoietin against cisplatin-induced peripheral neurotoxicity in rats. | 2004 |
1 |
| 30 |
15634645 | Erythropoietin induces cancer cell resistance to ionizing radiation and to cisplatin. | 2004 Dec |
2 |
| 31 |
12694652 | Molecular determinants of epothilone B derivative (BMS 247550) and Apo-2L/TRAIL-induced apoptosis of human ovarian cancer cells. | 2003 Apr |
3 |
| 32 |
12759237 | Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. | 2003 Jun |
1 |
| 33 |
12835520 | Protection against cisplatin-induced nephrotoxicity by recombinant human erythropoietin. | 2003 |
2 |
| 34 |
12161978 | [Erythropoietin and cisplatin-induced neuropathies in cancer patients]. | 2002 May-Jun |
1 |
| 35 |
11379400 | [Decline in the need for blood transfusions in cancer patients due to the use of epoietin alfa during cisplatin based chemotherapy]. | 2001 May 5 |
1 |
| 36 |
11574136 | Serum erythropoietin levels in ovarian cancer patients receiving chemotherapy. | 2001 Oct |
5 |
| 37 |
11828949 | Double-blind randomized control trial of the effect of recombinant human erythropoietin on chemotherapy-induced anemia in patients with non-small cell lung cancer. | 2001 Dec |
1 |
| 38 |
10930966 | Plasma erythropoietin concentrations in patients receiving intensive platinum or nonplatinum chemotherapy. | 2000 Aug |
2 |
| 39 |
11090055 | Cadmium and platinum suppression of erythropoietin production in cell culture: clinical implications. | 2000 Dec 1 |
2 |
| 40 |
11188780 | Mechanisms of anaemia in patients with malignancy: implications for the clinical use of recombinant human erythropoietin. | 2000 Nov |
1 |
| 41 |
11326688 | Human hematopoietic growth factors: old lessons and new perspectives. | 2000 Nov-Dec |
1 |
| 42 |
9925862 | Recombinant human erythropoietin treatment for chemotherapy-related anemia in children. | 1999 Feb |
1 |
| 43 |
10023014 | Assessment of the efficacy of two dosages and schedules of human recombinant erythropoietin in the prevention and correction of cisplatin-induced anemia in cancer patients. | 1999 Mar-Apr |
2 |
| 44 |
10329047 | Effects of recombinant human erythropoietin on the antitumor effect of cisplatin in SCID mice bearing human ovarian cancer: A possible oxygen effect. | 1999 May |
3 |
| 45 |
10561191 | Erythropoietin addition to granulocyte colony-stimulating factor abrogates life-threatening neutropenia and increases peripheral-blood progenitor-cell mobilization after epirubicin, paclitaxel, and cisplatin combination chemotherapy: results of a randomized comparison. | 1999 Apr |
1 |
| 46 |
9776431 | Does cisplatin stimulate erythropoietin secretion from the peritubular cells of the kidney? | 1998 Sep |
1 |
| 47 |
9874467 | What are cancer patients willing to pay for prophylactic epoetin alfa? A cost-benefit analysis. | 1998 Dec 15 |
1 |
| 48 |
9365742 | [Haematopoietic growth factors and solid tumors]. | 1997 |
1 |
| 49 |
8768296 | [Erythropoietin in oncology. II. Evaluation of the effectiveness of erythropoietin in hematologic and oncologic diseases]. | 1996 May |
1 |
| 50 |
7637961 | Recombinant human erythropoietin treatment in elderly cancer patients with cisplatin-associated anemia. | 1995 Sep-Oct |
3 |